Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients

Breast Cancer Res. 2022 Jul 15;24(1):50. doi: 10.1186/s13058-022-01539-7.

Courtney T van Geelen^#¹, Peter Savas^#^{1

2}, Zhi Ling Teo¹, Stephen J Luen^{1

2}, Chen-Fang Weng¹, Yi-An Ko¹, Keilly S Kuykhoven³, Franco Caramia¹, Roberto Salgado¹, Prudence A Francis^{2

4}, Sarah-Jane Dawson^{1

2

4}, Stephen B Fox^{1

5

4}, Andrew Fellowes⁵, Sherene Loi^{6

7

8}

¹ Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
² Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
³ Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation (CSIRO) Health and Biosecurity, Geelong, Australia.
⁴ Sir Peter MacCallum Department of Oncology, University of Melbourne, 305 Grattan St, Melbourne, VIC, 3000, Australia.
⁵ Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.
⁶ Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia. sherene.loi@petermac.org.
⁷ Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. sherene.loi@petermac.org.
⁸ Sir Peter MacCallum Department of Oncology, University of Melbourne, 305 Grattan St, Melbourne, VIC, 3000, Australia. sherene.loi@petermac.org.

^# Contributed equally.

No abstract available

Publication types